Skip to content
    Contact us
    Pure Derm

    Managing the Drivers of Dermatology Spend

    A comprehensive dermatology solution delivering up to 25% savings through value-based provider reimbursement, treatment pathway management, and specialty pharmacy oversight.

    Dermatology Spend Starts Long Before a Claim Becomes Costly

    Dermatology is a growing driver of both medical and pharmacy spend for health plans. From skin cancer surveillance and procedural care to chronic conditions such as psoriasis and eczema, the decisions made throughout the care journey can have a significant impact on outcomes and cost

    Health plans face a common challenge: ensuring members receive timely care, appropriate treatment, and consistent follow-up while managing rising specialty utilization and pharmacy expenses. When care gaps persist or treatment pathways vary significantly, costs often increase while quality and visibility decline.

    Pure Derm helps health plans take a more proactive approach to dermatology management through clinical oversight, provider accountability, specialty pharmacy stewardship, and targeted programs designed to improve outcomes while managing total cost of care.

    6.1M Adults Treated for Skin Cancer Annually

    Skin cancer remains the most common cancer diagnosis in the United States and a major source of specialty utilization. 

    Follow-Up Gaps Increase Long-Term Risk

    Members diagnosed with skin cancer require ongoing surveillance and follow-up to support earlier identification of recurrence and progression.

    Advanced Therapies Average $40K PMPY

    Psoriasis and eczema treatment can create significant specialty pharmacy exposure, with some biologics costing up to $95,000 per member per year. 

    UVB Therapy Is Often Underutilized

    Guideline-supported phototherapy is frequently bypassed despite its role in treatment pathways that precede advanced therapies. 

    A Proactive Model for Managing Dermatology Risk

    Pure Derm helps health plans identify care gaps, reduce unnecessary variation, and create greater accountability across dermatology care. By combining provider engagement, clinical oversight, treatment pathway management, and specialty pharmacy stewardship, Pure Derm addresses the factors that most directly influence outcomes and spend.

    Icon_Presenter With Analytics Board

    Data-Driven Visibility

     Claims-based insights help identify care gaps, treatment variation, high-cost utilization patterns, and opportunities for earlier intervention.  

    Icon_Male Provider 2

    Provider Accountability

     Value-based reimbursement aligns incentives around quality, outcomes, access, and cost management.  

    Icon_Team Collaboration Settings

    Treatment Pathway Management

     Clinical oversight promotes evidence-based treatment decisions and more consistent dermatology care across providers and treatment settings.  

    Icon_Financial Search Network

    Specialty Pharmacy Stewardship

     Targeted programs and guideline-supported pathways help manage biologic utilization while supporting appropriate care.  

    Pure Derm In Action

    Melanoma Follow-Up Program

    Members diagnosed with melanoma face ongoing risk of recurrence and progression without timely follow-up care. Pure Derm uses claims-based monitoring and targeted outreach to help health plans identify members who may be overdue for recommended surveillance, supporting earlier intervention, continuity of care, and reduced downstream costs associated with delayed detection. 

    iStock-2227521767_healthcare_male_patient_dermatology_skin check

    Clear Skin: A Better Pathway for Psoriasis and Eczema Care

    Clear Skin extends the Pure Derm model into one of the fastest-growing areas of specialty spend. Designed for members with psoriasis and eczema, the program improves access to guideline-supported UVB phototherapy before progression to high-cost advanced therapies.

    For many health plans, rising dermatology pharmacy costs are being fueled by increasing utilization of biologics and biosimilars. Yet UVB phototherapy remains a recommended step in the treatment pathway and is frequently bypassed due to limited access, provider burden, and the challenges associated with traditional phototherapy delivery.

    Powered in partnership with Zerigo Health, Clear Skin is a value-based dermatology program designed to improve access to guideline-supported treatment for psoriasis and eczema. Through in-home UVB phototherapy, provider engagement, and ongoing clinical support, the program removes those barriers and helps members access appropriate therapy earlier while avoiding higher cost biologics.

     

    • High-Cost Therapies Continue to Grow
      Psoriasis and eczema treatment can exceed $40,000 per member per year, with some biologics approaching $95,000 annually. Demand continues to rise as specialty pharmacy utilization increases.  
    • Members are Looking for Better Options
      Only 28% of members report being satisfied with their current treatment, creating opportunities to improve both experience and outcomes.  
    • Guideline-Supported Treatment Is Often Skipped
      UVB phototherapy is a recommended step in the treatment pathway for psoriasis and eczema, yet providers utilize biologics and biosimilars at approximately five times the rate of UVB therapy.  
    • Bringing UVB Therapy Home

      Powered in partnership with Zerigo Health, Clear Skin combines an FDA-cleared handheld UVB device, personalized treatment plans, mobile technology, and dedicated support to help members begin treatment quickly and stay engaged throughout their care journey.

    Clear Skin Brings Home Guideline-Supported Care

    UVB phototherapy is a recommended treatment option for psoriasis and eczema, but access challenges often make it easier to move directly to advanced biologics. As specialty pharmacy costs continue to rise, health plans need a better way to help members access appropriate care earlier in their treatment journey.

    Clear Skin addresses that challenge through a fully supported, at-home treatment model. In partnership with Zerigo Health, the program combines an FDA-cleared handheld UVB device, personalized treatment plans, mobile technology, provider engagement, and ongoing clinical support to help members begin treatment quickly and remain engaged throughout their care journey.

    By improving access to guideline-supported therapy, Clear Skin helps health plans create a lower-cost treatment pathway while supporting adherence, member experience, and better clinical outcomes.

    Female_Light-Device_Ktichen_0744_smaller

    Results That Matter

    $10K+ PMPY

    Savings for Identified Members

    2:1

    Guaranteed
    ROI 

    80%

    Clinical Improvement
    at 12 Weeks

    75%

    Member Adherence

    Let's Make a Mark in Specialty Management

    Pure Derm helps health plans improve outcomes, close care gaps, and manage the clinical and pharmacy drivers of dermatology spend through a more accountable approach to specialty care.

    Download Pure Derm Overview